期刊文献+

In situ synthesis of graphene oxide/gold nanorods theranostic hybrids for efficient tumor computed tomography imaging and photothermal therapy 被引量:4

In situ synthesis of graphene oxide/gold nanorods theranostic hybrids for efficient tumor computed tomography imaging and photothermal therapy
原文传递
导出
摘要 Graphene oxide/gold nanorod (GO/GNR) nanohybrids were synthesized with a GO- and gold-seed-mediated in situ growth method at room temperature by mixing polystyrene sulfonate (PSS) functionalized GO, secondary growth solution, and gold seeds. Compared with ex situ preparation methods of GO/GNRs or graphene (G)/GNRs, the in situ synthesis of GO/GNRs addressed the issue of the aggregation of the GNRs before their attachment onto the GO. The method is straightforward and environment-friendly; The GO/GNRs showed a remarkable photothermal effect in vitro. The temperature of the GO/GNR nanohybrids increased from 25 to 49.9 ℃ at a concentration of 50 μg/mL after irradiation with an 808-nm laser (0.4 W/cm2) for 6 min. Additionally; the GO/GNRs exhibited good optical and morphological stability and photothermal properties after six cycles of laser irradiation. Upon injection of the GO/GNRs into xenograft tumors, excellent computed tomography (CT) imaging properties and photothermal effect were obtained. The preclinical CT agent iohexol was combined with the GO/GNRs and further enhanced CT imaging. Therefore, the GO/GNR nanohybrids have great potential for predse CT-image-guided tumor photothermal treatment. Graphene oxide/gold nanorod (GO/GNR) nanohybrids were synthesized with a GO- and gold-seed-mediated in situ growth method at room temperature by mixing polystyrene sulfonate (PSS) functionalized GO, secondary growth solution, and gold seeds. Compared with ex situ preparation methods of GO/GNRs or graphene (G)/GNRs, the in situ synthesis of GO/GNRs addressed the issue of the aggregation of the GNRs before their attachment onto the GO. The method is straightforward and environment-friendly; The GO/GNRs showed a remarkable photothermal effect in vitro. The temperature of the GO/GNR nanohybrids increased from 25 to 49.9 ℃ at a concentration of 50 μg/mL after irradiation with an 808-nm laser (0.4 W/cm2) for 6 min. Additionally; the GO/GNRs exhibited good optical and morphological stability and photothermal properties after six cycles of laser irradiation. Upon injection of the GO/GNRs into xenograft tumors, excellent computed tomography (CT) imaging properties and photothermal effect were obtained. The preclinical CT agent iohexol was combined with the GO/GNRs and further enhanced CT imaging. Therefore, the GO/GNR nanohybrids have great potential for predse CT-image-guided tumor photothermal treatment.
出处 《Nano Research》 SCIE EI CAS CSCD 2017年第1期37-48,共12页 纳米研究(英文版)
基金 Acknowledgements This work was financially supported by National Natural Science Foundation of China (No. 51302190), Shanghai Natural Science Foundation (No. 16ZR1400700) and Shanghai Health and Family Planning Commission Project (Nos. 20144Y0248 and 2012y193). We are extremely grateful to Prof. Wei An (Tongji University) for great help with infrared thermal camera. We also thank Mr. Chengwei Shao (Changhai Hospital) for kind help with commercial iohexol and SW1990 tumor cells.
关键词 graphene oxide/goldnanorods in situ growth computed tomographyimaging photothermal therapy graphene oxide/goldnanorods,in situ growth,computed tomographyimaging,photothermal therapy
分类号 O [理学]
  • 相关文献

参考文献4

二级参考文献44

  • 1Lovell, J. F.; Liu, T.; Chen, J., Zheng, G. Activatable photosensitizers for imaging and therapy. Chem. Rev. 2010, 110, 2839-2857.
  • 2Celli, J. P.; Spring, B. Q.; Rizvi, I.; Evans, C. L.; Samkoe, K. S.; Verma, S.; Pogue, B. W.; Hasan, T. Imaging and photodynamic therapy: Mechanisms, monitoring and optimization. Chem. Rev. 2010, 110, 2795-2838.
  • 3Dolmans, D. E. J. G. J.; Fukumura, D.; Jain, R. K. Photo- dynamic therapy for cancer. Nat. Rev. Cancer 2003, 3, 380-387.
  • 4Agostinis, P.; Berg, K.; Cengel, K. A., Foster, T. H.; Girotti, A. W.; Gollnick, S. O.; Hahn, S. M.; Hamblin, M. R., Juzeniene, A.; Kessel, D. et al. Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 2011, 61,250-281.
  • 5Dougherty, T. J.; Gomer, C. J.; Henderson, B. W.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q. Photodynamic therapy. J. Natl. Cancer Inst. 1998, 90, 889-905.
  • 6Bugaj, A. M. Targeted photodynamic therapy-a promising strategy of tumor treatment. Photochem. PhotobioL Sci. 2011, 10, 1097-1109.
  • 7Allison, R. R.; Downie, G. H.; Cuenca, R.; Hu, X. H.; Childs, C. J.; Sibata, C. H. Photosensitizers in clinical PDT. Photodiagn. Photodyn. Ther. 2004, 1, 2742.
  • 8Yang, H. Y.; Wang, F. Y.; Zhang, Z. Y. Photobleaching of chlorins in homogeneous and heterogeneous media. Dyes Pigm. 1999, 43, 109-117.
  • 9Lovell, J. F.; Jin, C. S.; Huynh, E.; Jin, H.; Kim, C.; Rubinstein, J. L.; Chan, W. C. W.; Cao, W. G.; Wang, L. H. V.; Zheng, G. Porphysome nanovesicles generated by porphyrinbilayers for use as multimodal biophotonic contrast agents. Nat. Mater. 2011, 10, 324-332.
  • 10Davies, A.; Lewis, D. J.; Watson, S. P.; Thomas, S. G.; Pikramenou, Z. pH-controlled delivery of luminescent europium coated nanoparticles into platelets. Proc. Natl. Acad. Sci. USA 2012, 109, 1862-1867.

共引文献40

同被引文献9

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部